ReportWire

Tag: TG Therapeutics Inc

  • Stocks making the biggest moves midday: Amazon, Lennar, GoodRX, Gilead Sciences & more

    Stocks making the biggest moves midday: Amazon, Lennar, GoodRX, Gilead Sciences & more

    [ad_1]

    [ad_2]

    Source link

  • Stocks making the biggest moves midday: TG Therapeutics, Micron Technology, ChargePoint and more

    Stocks making the biggest moves midday: TG Therapeutics, Micron Technology, ChargePoint and more

    [ad_1]

    A ChargePoint station at the New Carrollton Branch Library in New Carrollton, Md.

    Tom Williams | Cq-roll Call, Inc. | Getty Images

    Check out the companies making headlines in midday trading.

    TG Therapeutics — Shares jumped more than 9% after the biotech company announced this week that the U.S. Food and Drug Administration approved its treatment for relapsing forms of multiple sclerosis in adults.

    Micron Technology — Shares of the chipmaker dropped 2% after the stock got downgraded to hold from buy by Argus Research. The firm cited the potential for deep operating losses in upcoming quarters.

    GlobalFoundries — Shares of the semiconductor manufacturer lost more than 1% a day after a report that the company will lay off 50 workers from its former California headquarters, according to the Silicon Valley Business Journal.

    ChargePoint — The maker of EV charging technology saw shares rise more than 4% after Q-GRG VII (CP) Investment Partners bought more than 1.4 million shares, according to a filing with the Securities and Exchange Commission.

    Nikola — Shares of the electric vehicle company fell more than 6% Friday. The move came as the company announced plans to raise cash by selling up to $125 million of senior convertible bonds

     — CNBC’s Nick Wells, Alex Harring, Sarah Min and Samantha Subin contributed reporting

    [ad_2]

    Source link

  • Stocks making the biggest moves midday: Netflix, Cal-Maine Foods, Southwest and more

    Stocks making the biggest moves midday: Netflix, Cal-Maine Foods, Southwest and more

    [ad_1]

    In this photo illustration the Netflix logo seen displayed on a smartphone screen, with graphic representation of the stock market in the background.

    Sopa Images | Lightrocket | Getty Images

    Check out the companies making headlines in midday trading.

    Netflix — The streaming giant gained 6.3% following a double upgrade to buy from sell by CFRA. The firm said it would be difficult for competitors to catch up with the company.

    Cal-Maine Foods — Cal-Maine shares shed 15% after reporting earnings that fell short of Wall Street’s expectations even as the egg producer reported record sales. The company said the avian flu outbreak limited supply and pushed prices up.

    Southwest Airlines —  The airline stock rose more than 3%, paring back losses from the previous session when it dropped more than 5%. Severe disruptions at Southwest Airlines have drawn outsized criticism from frustrated travelers, who have dealt with thousands of canceled flights from airlines this week because of winter weather. Southwest Airlines canceled another 60% of its flights on Wednesday. According to The Dallas Morning News, it’s expected to restore its full schedule on Friday.

    Lockheed Martin — The defense contractor’s stock rose nearly 1% following news that its Sikorsky unit is contesting a U.S. Army helicopter contract awarded to Textron. It said proposals for the $1.3 billion contract were not evaluated fairly. Textron shares were last up 1.9%.

    Tesla — Tesla shares gained more than 7% after selling off during the previous sessions and 37% this month. The stock’s headed for one of its worst months, quarters and years ever.

    Apple — The iPhone maker’s stock rose more than 3% after hitting its lowest level since June 2021 earlier in the week.

    General Electric — Shares rose 1.7% amid news that General Electric’s health-care spinoff will join the S&P 500 when it starts trading separately on Jan. 4. GE Healthcare will replace Vornado Realty Trust, set to join the S&P MidCap 400.

    ImmunoGen — Shares added 6.2% after the biotechnology company announced CFO Susan Altschuller would not return from her time off. Renee Lentini, the vice president and chief accounting officer, was named interim CFO. The stock initially dropped in premarket trading.

    TG Therapeutics — The biopharmaceutical stock soared more than 29% on news that the U.S. Food and Drug Administration approved its drug to treat relapsing forms of multiple sclerosis. The drug, known as Briumvi, is expected to roll out during the first quarter of 2023.

    — CNBC’s Alex Harring and Sarah Min contributed reporting

    [ad_2]

    Source link